Issue 5, 2013
HOT TOPICS IN CARDIOMETABOLIC DISORDERS
Potential effects of vildagliptin on cardiovascular disease
Since this monograph has no abstract, we have provided an extract of the first 100 words of the first article.
Dipeptidyl peptidase-4 (DPP-4) inhibitors have been available for the treatment of type 2 diabetes for over 5 years. Vildagl ...